Semaglutide · GLP-1 medication

Semaglutide for weight loss: cost, results and how to start online

Semaglutide is the active ingredient in Wegovy® and Ozempic®. A licensed Zealthy provider reviews your health history online and, when appropriate, prescribes a brand-name product or compounded semaglutide.

  • Wegovy 2.4 mg: 14.9% average weight loss at 68 weeks, against 2.4% on placebo1
  • Brand-name Wegovy or Ozempic: the copay can be as low as $25/mo if your plan covers it*
  • Compounded semaglutide $199/mo, or from $106/mo with a 3-month supply, shipping included†
  • Reviewed online by a licensed provider in all 50 states. No appointment needed to start
Two glass vials with white labels reading Zealthy, GLP-1, Semaglutide and Prescription Only, on a green background
Compounded semaglutide · from $106/mo†
Five Wegovy injection pens stacked one above another, each with a different colored dose label
Brand Wegovy · copay as low as $25/mo if covered*
Two blue Ozempic injection pens with gray caps
Brand Ozempic · FDA-approved for type 2 diabetes
Close-up of a hand holding a blue injection pen against the side of a thigh
Injected under the skin once a week
Hand holding a phone that shows a Zealthy intake question about weight loss goals
Reviewed by a licensed provider
$106/moCompounded semaglutide, starting price with a 3-month supply†
$25/moBrand Wegovy or Ozempic copay can be this low when insurance covers it*
$39Zealthy membership, first month
What is semaglutide?

It is a prescription GLP-1 medicine made by Novo Nordisk. It acts like a hormone released after meals, so appetite drops and the stomach empties more slowly.2 See every product that contains it.

Is compounded semaglutide the same as Wegovy or Ozempic?

No. A pharmacy prepares it for one patient’s prescription. It is neither FDA-approved nor a generic, and the FDA does not review compounded drugs for safety, effectiveness or quality.3 Trial results on this page belong to the approved products. More on compounded semaglutide.

Semaglutide or tirzepatide?

Tirzepatide (Zepbound®, Mounjaro®) acts on GLP-1 and a second receptor, GIP. In SURMOUNT-5, which ran 72 weeks, average weight loss was 13.7% with semaglutide and 20.2% with tirzepatide.4 Compare the two.

*You need a commercial plan that covers the brand you are prescribed, plus Novo Nordisk’s savings offer. Savings are capped, and the offer is closed to people with Medicare, Medicaid, VA, TRICARE or another government program.5,6 An active Zealthy membership is required, and approval is not guaranteed. †From $106 a month with a 3-month supply, or $199 month to month. Compounded medication is not FDA-approved. Membership ($39 first month, then $135 a month) is separate.

Safety summary: The boxed warning for semaglutide concerns thyroid C-cell tumors. It is not for anyone who has had medullary thyroid carcinoma (MTC), has a relative who had it, or has MEN 2. Full safety information.

Semaglutide 2.4 mg led to 15.2% average weight loss over two years

The figure comes from STEP 5, a 104-week trial of Wegovy’s dose, semaglutide 2.4 mg once a week. It enrolled 304 adults with obesity, or overweight plus a weight-related condition, and no diabetes. The placebo group lost 2.6%, and both groups had behavioral support.7 Results vary, and these are not results for compounded semaglutide.

Pounds lost at the
trial’s 15.2% average
38lbs

STEP 5 placebo group, at the same weight: about 7 lbs

Arithmetic on one trial’s average for FDA-approved Wegovy, not a forecast of your result.

Semaglutide weight loss results, trial by trial

TrialWho took partDose and lengthAverage weight lossPlacebo
STEP 111,961 adults without diabetesInjection, 2.4 mg weekly, 68 weeks14.9%2.4%
STEP 57304 adults without diabetesInjection, 2.4 mg weekly, 104 weeks15.2%2.6%
STEP UP2Adults with obesity, without diabetesInjection, 7.2 mg weekly, 72 weeks18.8% (15.5% on 2.4 mg)3.9%
OASIS 42Adults without diabetesTablets, 25 mg daily, 64 weeks13.6%2.4%

Adults with type 2 diabetes lost less, 9.6% in the STEP 2 trial.2 In STEP 4, adults moved to placebo after 20 weeks regained 6.9% of their weight over the next 48 weeks, while those who continued lost another 7.9%.8 In the SELECT heart trial of 17,604 adults with cardiovascular disease, heart attack, stroke or cardiovascular death occurred in 6.5% on semaglutide 2.4 mg and 8.0% on placebo.2

What is semaglutide, and which medications contain it?

One active ingredient, several products, each with its own approved uses and doses.

ProductFDA-approved forHow it is takenDose strengths
Wegovy injectionWeight reduction in adults and children 12 and older with obesity, and adults with overweight plus a weight-related condition. Lower heart risk for adults who have cardiovascular disease along with excess weight. The liver disease MASH in adults.2Weekly injection0.25 to 2.4 mg, and 7.2 mg for adults
Wegovy tabletsWeight reduction and lower heart risk in adults. Not for children or MASH.2Daily tablet on an empty stomach1.5, 4, 9 and 25 mg
Ozempic injectionType 2 diabetes in adults, including lower heart and kidney risk in certain adults. It has no weight loss approval, so that use is off-label.9Weekly injection0.25 mg to start, then 0.5, 1 or 2 mg
Ozempic tablets, Rybelsus®Type 2 diabetes in adults.10Daily tablet1.5, 4 and 9 mg (Ozempic tablets). 3, 7 and 14 mg (Rybelsus)
Compounded semaglutideNo FDA approval. The agency does not review compounded drugs for safety, effectiveness or quality.3From a vial, as prescribedSet by your provider

How semaglutide works

Semaglutide is 94% similar to GLP-1, a hormone your body makes. It acts on the same receptors, including ones in brain areas that regulate appetite, so people eat less. It also slows stomach emptying and prompts insulin release when blood sugar is high.2,9

Its half-life is about one week, which is why the injection is weekly. Our GLP-1 meaning guide explains the drug class.

In short

  • First approved in December 2017, as Ozempic for type 2 diabetes.11
  • Wegovy is the brand approved for weight. It should not be combined with another semaglutide or GLP-1 product.2

How to get semaglutide online through Zealthy

Semaglutide needs a prescription. Zealthy’s review happens online, for eligible adults in all 50 states.

Five steps from sign-up to first dose
1. Answer the health questions

Create your account and complete the intake: medical history, current medications, weight and goals. The first month of membership costs $39.

Hand holding a phone that shows a Zealthy intake question about weight loss goals
2. A licensed provider reads your answers

A U.S.-licensed physician or nurse practitioner decides whether semaglutide is appropriate. No live appointment is required to start. Video or phone visits are included if you want one.

A provider in a white coat with a stethoscope, shown on a phone screen
3. Our team works with your insurance

For brand-name Wegovy or Ozempic, the insurance coordination team submits the prior authorization. When your plan covers it, the copay can be as low as $25 a month. Approval is your plan’s decision.

Black and white portrait of a smiling woman with curly hair
4. Your medication is filled

Brand-name prescriptions go to your own pharmacy. Compounded semaglutide ships to your home from a partner pharmacy, usually after 2 to 7 business days of processing, with supplies included.

Black and white photo of two women laughing together
5. Stay in touch as your dose changes

Message your care team whenever you need and work with your weight loss coach. Your provider decides when to raise, hold or lower the dose.

Black and white portrait of a smiling woman resting her hand against her cheek
Woman with curly hair laughing, hands on her hips, in a patterned sports top against a coral wall

What a Zealthy membership covers

  • Review by a licensed provider
  • An insurance coordination team for brand-name prior authorizations
  • Unlimited secure messaging with your care team
  • Optional monthly video or phone visits
  • A weight loss coach, the Zealthy app and the online portal

$39 the first month, $135 a month after that. Medication is not included.

Get Started

Semaglutide side effects: label percentages and serious risks

Stomach and bowel symptoms are the most common side effects. In Wegovy’s adult weight trials, 73% of people on 2.4 mg reported at least one, against 47% on placebo.2

Wegovy injection, adult weight trials

Side effectWegovy 2.4 mgPlacebo
Nausea44%16%
Diarrhea30%16%
Vomiting24%6%
Constipation24%11%
Abdominal pain20%10%

Ozempic injection, type 2 diabetes trials

Side effect0.5 mg1 mgPlacebo
Nausea15.8%20.3%6.1%
Diarrhea8.5%8.8%1.9%
Vomiting5%9.2%2.3%
Constipation5%3.1%1.5%
Abdominal pain7.3%5.7%4.6%

Adults reporting each effect in placebo-controlled trials of the FDA-approved injections.2,9 Wegovy 2.4 mg trials also recorded headache (14%), fatigue (11%), indigestion (9%), dizziness (8%) and hair loss (3%). These rates were not measured for compounded semaglutide.

When do semaglutide side effects happen?

Mostly while the dose is going up, according to both labels. In the Wegovy trials, 6.8% of adults on 2.4 mg stopped treatment because of side effects, against 3.2% on placebo. At 7.2 mg, altered skin sensation was reported by 22% of adults, against 6% at 2.4 mg.2,9

On November 9, 2026 the FDA said every GLP-1 label, Wegovy and Ozempic included, must add a warning about a potential increased risk of NAION, a rare cause of sudden vision loss in one eye.12 Our GLP-1 side effects guide covers the whole class.

Boxed warning: semaglutide is not for anyone who has had medullary thyroid carcinoma, has a close relative who had it, or has MEN 2. See who should not take it.

Ways to ease side effects

  • Tell your provider early. The Wegovy label allows a dose increase to be delayed by four weeks.2
  • Keep drinking fluids if you are vomiting or have diarrhea. Dehydration can injure the kidneys.2

Get medical help right away for

  • Severe stomach pain that will not go away, with or without vomiting.
  • Upper stomach pain with fever, yellow skin or eyes, or clay-colored stools.
  • A swollen face, lips, tongue or throat, difficulty breathing, or a severe rash.
  • Sudden loss of vision in one eye.
  • A neck lump, a hoarse voice or difficulty swallowing (boxed warning).

Semaglutide dosing schedule

Every FDA-approved semaglutide product starts low and steps up about once a month to limit stomach side effects. These are the fastest schedules the labels allow.

WhenWegovy injection, weeklyOzempic injection, weeklyWegovy tablets, daily
Weeks 1 to 40.25 mg0.25 mg1.5 mg (days 1 to 30)
Weeks 5 to 80.5 mg0.5 mg4 mg (days 31 to 60)
Weeks 9 to 121 mg0.5 mg, or 1 mg if needed9 mg (days 61 to 90)
Weeks 13 to 161.7 mg0.5 or 1 mg, or 2 mg if needed25 mg (from day 91)
Week 17 onward2.4 mg, or 1.7 mg0.5, 1 or 2 mg25 mg
  1. 0.25 mgWeeks 1 to 4
  2. 0.5 mgWeeks 5 to 8
  3. 1 mgWeeks 9 to 12
  4. 1.7 mgWeeks 13 to 16
  5. 2.4 mgWeek 17 onward
  6. 7.2 mgOptional, adults only

From the prescribing information for the FDA-approved products.2,9 Compounded semaglutide has no FDA-approved schedule. Your provider sets the dose on your prescription.

The injections go under the skin of the abdomen, thigh or upper arm on the same day each week, with or without food. A missed Wegovy injection can be taken if the next dose is more than 2 days away. With Ozempic, the window is 5 days.2,9 Our Ozempic dosage guide goes pen by pen.

Semaglutide vs tirzepatide: how the two compare

Tirzepatide led to more weight loss on average in the one large obesity trial that tested both. Semaglutide has tablets and a heart-risk approval.

FeatureSemaglutideWegovy, OzempicTirzepatideZepbound, Mounjaro
TargetsThe GLP-1 receptorThe GLP-1 and GIP receptors
First U.S. approvalOzempic, 2017Mounjaro, 2022
Head-to-head weight loss in obesity13.7% after 72 weeks20.2% after 72 weeks
Head-to-head weight loss in type 2 diabetes5.7 kg (12.6 lb) at 40 weeks on 1 mg7.6 to 11.2 kg (16.8 to 24.7 lb) at 40 weeks on 5 to 15 mg
Weekly dose for weight1.7 or 2.4 mg, up to 7.2 mg for adults5, 10 or 15 mg
Other approved usesHeart-risk reduction, MASH, type 2 diabetesObstructive sleep apnea with obesity, type 2 diabetes
Tablet formYesNo, injection only
Compounded, through ZealthyFrom $106/mo with a 3-month supply, or $199 month to monthFrom $216/mo with a 3-month supply, or $329 month to month

The direct-comparison numbers come from SURMOUNT-5 and SURPASS-2.4,13 Other rows are from each brand’s prescribing information.2,9,14,15 Compounded medications are not FDA-approved.

Which one produces more weight loss?

On average, tirzepatide. SURMOUNT-5 gave 751 adults with obesity, and without type 2 diabetes, the highest dose they could tolerate of either drug for 72 weeks. Average loss was 20.2% with tirzepatide (10 or 15 mg) and 13.7% with semaglutide (1.7 or 2.4 mg).4 Participants knew which drug they took, Eli Lilly funded the trial, and Wegovy 7.2 mg was not tested.

When semaglutide may fit better

Wegovy has an approval for cutting heart attack and stroke risk in adults who have cardiovascular disease along with excess weight, diabetes or not. Zepbound has no heart indication, and Mounjaro’s covers only adults with type 2 diabetes.2,14,15

Side effects are the same kind for both. In SURPASS-2, nausea affected 17% to 22% of people on tirzepatide and 18% on semaglutide 1 mg.13 Our tirzepatide page has its full table.

Prices as of November 2026

How much does semaglutide cost?

Semaglutide can cost $25 a month with covered insurance or carry a list price above $1,300. How you pay matters far more than your dose.

Your situationWhat you may payDetails
Wegovy, when your commercial plan covers itFrom $25 a monthThe Novo Nordisk savings offer removes up to $100 from a 1-month fill of pens or tablets.5
Ozempic, when your commercial plan covers itFrom $25 a fillSavings are capped at $100 for 1 month, $200 for 2 and $300 for 3.6
Brand-name, paying on your own$349 a month for most pensWegovy 7.2 mg is $399 and Ozempic 2 mg is $499. New patients pay $199 for the first two fills of 0.25 or 0.5 mg, through December 31, 2026.5,6,16
Brand-name list price$1,349.02 Wegovy, $1,027.51 OzempicPer package, before insurance or discounts.17,18
Compounded semaglutide through Zealthy$199 a month, or from $106 a month with a 3-month supplyShipping included. Not FDA-approved. Prescribed only when a provider finds it appropriate.
Medicare, Medicaid, VA, TRICARE or another government programManufacturer savings offers cannot be usedSince July 1, 2026, eligible Part D enrollees can get Wegovy for a $50 monthly copay through the temporary Medicare GLP-1 Bridge. It needs a prior authorization, which stays valid through December 31, 2027.19

Novo Nordisk can change its prices and offers. Zealthy medication prices exclude membership.

Semaglutide cost with insurance

With coverage, brand-name semaglutide can cost as little as $25 a month. Plans generally cover GLP-1 medicines for diabetes, but in KFF’s 2026 survey only 18% of employers with 200 or more workers covered them for weight loss.20 Try our GLP-1 insurance checker.

Semaglutide cost without insurance

Without insurance, most Wegovy and Ozempic pens are $349 a month at Novo Nordisk’s self-pay price. Wegovy tablets are $149 a month at 1.5 mg, $199 at 4 mg and $299 at 9 or 25 mg.5 Self-pay purchases sit outside insurance, so they cannot be reimbursed or counted toward a deductible.6

Manufacturer savings offers and NovoCare Pharmacy

There is no single semaglutide coupon. Novo Nordisk runs one savings offer for Wegovy and another for Ozempic. Each needs a commercial plan covering that brand, and neither works with government coverage.5,6 NovoCare Pharmacy, the company’s direct channel, delivers to your home at no charge with a prescription.16 See our GoodRx Wegovy guide for coupon sites.

What semaglutide costs through Zealthy

  • Membership: $39 the first month, $135 a month after that.
  • Brand-name Wegovy or Ozempic: filled at your own pharmacy. The copay can be as low as $25 a month when your plan covers it.
  • Compounded semaglutide: $199 a month, or from $106 a month with a 3-month supply, shipping included.
  • Bundle: membership and compounded semaglutide together, $217 for the first month, then $297 a month.

Compounded semaglutide: what it is and where the FDA stands

Compounded semaglutide is made by a pharmacy for one patient’s prescription. It is not FDA-approved and not a generic, and the FDA does not review compounded drugs for safety, effectiveness or quality.3

FeatureBrand-name semaglutideWegovy or OzempicCompounded semaglutideThrough Zealthy
Made byNovo NordiskA partner pharmacy, for your prescription
FDA statusFDA-approved for the uses on each labelNo FDA approval, and no FDA review of safety, effectiveness or quality
Clinical trialsSTEP, SELECT, OASIS and othersNot studied in any trial on this page
FormPrefilled pens or tabletsVials, with supplies included
Medication priceCopay can be as low as $25 a month if your plan covers it$199/mo, or from $106/mo with a 3-month supply
How it reaches youSent to your own pharmacyShipped to your home, usually within 2 to 9 business days

Can pharmacies still compound semaglutide?

Only within limits. Pharmacies could make copies while semaglutide injection was in shortage. The FDA declared the shortage over on February 21, 2025, and its grace periods ended on April 22, 2025 for state-licensed pharmacies and May 22, 2025 for outsourcing facilities.21

In its April 1, 2026 update, the FDA said a state-licensed pharmacy may compound for an individual patient with a prescription. It may not, regularly or in inordinate amounts, make what is essentially a copy of a commercially available drug unless the prescriber documents a change that makes a significant difference for that patient. Adding an ingredient such as vitamin B12 may still count as a copy.21 The agency says compounded drugs should be used only when an approved drug cannot meet a patient’s medical need.3

Risks the FDA has flagged

  • Dosing errors. Overdoses, some needing hospital care, after patients drew up 5 to 20 times the intended dose from vials.22
  • Salt forms. Semaglutide sodium and acetate are different active ingredients from the approved drug.3
  • Reports. 990 adverse event reports for compounded semaglutide by May 31, 2026.3

How Zealthy handles it

Your Zealthy provider judges whether compounded semaglutide suits you. How much to draw up depends on the concentration printed on your vial, so follow your prescription label and message your care team if anything is unclear.

Semaglutide next to the other GLP-1 medications

Zealthy providers can prescribe four brand-name GLP-1 medications: two with semaglutide, two with tirzepatide.

MedicationActive ingredientApproved for weight lossApproved usesHighest weekly doseTablet version
WegovySemaglutideYesWeight, heart risk, MASH7.2 mgYes
OzempicSemaglutideNo, off-labelType 2 diabetes2 mgYes
ZepboundTirzepatideYesWeight, sleep apnea15 mgNo
MounjaroTirzepatideNo, off-labelType 2 diabetes15 mgNo

From each product’s prescribing information.2,9,14,15

Zealthy members

What Zealthy members say about the program

One of the things I appreciate most about semaglutide is its convenience. The once-weekly dosing schedule has made it incredibly easy to integrate into my routine. It's a relief to know that I don't have to worry about multiple daily injections or complicated medication schedules.
Michelle, 33 | Lost 48 pounds
I started semaglutide at the recommendation of my Zealthy provider and I'm so happy with that decision. I signed up for their weight loss program and they've been giving me everything I need to make better lifestyle choices to get results that last. And the program's super affordable. 10/10 I can't recommend this enough.
Michael, 37 | Lost 29 pounds
Getting support a weight loss program has always been hard for me. I had been wanting to start one with a medication component for a while and Zealthy was the first one that made it easy for me with weight loss shots sent to me. They made it SO affordable and the medical team is great.
Susanne, 60 | Lost 33 pounds
Since I started, I have already lost 35 pounds and feel so much better. My doctor also helped me get a prescription for ozempic and he is always available to answer my questions in the message portal. This made me feel a lot more comfortable and excited to lose weight.
Rachel | Zealthy Member
The weight loss program is fantastic. Everyone has been so helpful and has helped me feel much more excited about the process. I was nervous to see my weight loss treatment plan, since I have done programs in the past, but they always wanted me to make drastic changes. I mentioned all of this to my weight loss coach and she was very understanding and made a customized plan for me.
John | Zealthy Member
I've been a member for 6 months now and have received all my medication every 3 months. Everyone has been so helpful and my care team is always available to help me!
Sara | Zealthy Member

Individual results may vary. These are the experiences of Zealthy members and are not a guarantee of any outcome. Medication is prescribed only when a licensed provider finds it appropriate.

A Zealthy provider shown on a phone screen
Your care team

Semaglutide is prescribed only after a licensed provider reads your history

U.S.-licensed physicians and nurse practitioners review your intake, decide whether a brand-name product or compounded semaglutide is appropriate, and adjust your dose as treatment goes on.

50 statesLicensed providers for members in every state
No appointment neededYour intake is reviewed online, and questions are handled by message
7 days a weekSupport Monday to Friday 9am to 6pm ET, weekends 12pm to 6pm ET

The medical information on this page is reviewed by the Zealthy care team against FDA prescribing information and published clinical trials. It is general education, not personal medical advice.

Semaglutide questions and answers

What is semaglutide used for?

It depends on the product. Wegovy’s approvals cover weight reduction, heart-risk reduction in certain adults, and the liver disease MASH. Ozempic’s cover type 2 diabetes, including heart and kidney protection in certain adults.2,9 Using Ozempic only for weight loss is off-label.

Are Ozempic and Wegovy the same medication?

They share one active ingredient and one maker, Novo Nordisk, but differ in approved use and dose. Ozempic is labeled for type 2 diabetes, with a 2 mg weekly maximum. Wegovy is labeled for weight reduction at 1.7 or 2.4 mg, with a 7.2 mg option for adults.2,9

What is the average weight loss on semaglutide?

In STEP 1, adults without diabetes on Wegovy 2.4 mg lost an average of 14.9% of their body weight in 68 weeks, against 2.4% on placebo.1 These are trial averages for FDA-approved semaglutide with lifestyle support. Individual results vary, and compounded semaglutide was not studied. See the trial table.

How long does semaglutide take to work?

Blood levels reach a steady state after four to five weeks of weekly doses.2 Weight change takes longer because the dose rises in steps. On the Wegovy schedule, 2.4 mg arrives at week 17 at the earliest, and the main trials measured results at 68 weeks or later.

Is semaglutide or tirzepatide better for weight loss?

Tirzepatide produced more weight loss on average in the only large obesity trial comparing them: 20.2% against 13.7% over 72 weeks.4 An average does not predict one person’s result. Semaglutide offers tablets and a heart-risk approval, and coverage and price matter too. See the comparison.

How much is semaglutide a month without insurance?

As of November 2026, Novo Nordisk’s self-pay price is $349 a month for most Wegovy and Ozempic pens.5,6 Compounded semaglutide through Zealthy is $199 a month, or from $106 a month with a 3-month supply, plus membership. The cost section lists every option.

Is compounded semaglutide FDA-approved?

No. Compounded semaglutide is not FDA-approved, and the FDA does not review compounded drugs for safety, effectiveness or quality. Nor is it a generic version of either brand.3 The trial results on this page come from the approved products. More under compounded semaglutide.

Can I get a semaglutide prescription online?

Yes. Zealthy’s review is done online: you answer health questions, and a U.S.-licensed physician or nurse practitioner reads them. No live appointment is required to start. Zealthy is available to eligible adults in all 50 states, and a prescription is written only when the provider finds treatment appropriate.

Important safety information

This summary draws on the Wegovy and Ozempic labels. Compounded semaglutide has no FDA-approved label, so treat every warning below as applying to it too.

Boxed warning: thyroid C-cell tumors

In rodent studies, semaglutide caused thyroid C-cell tumors, and the risk rose with dose and length of treatment. Whether it causes these tumors in people, including medullary thyroid carcinoma (MTC), is unknown. Semaglutide must not be used by anyone who has had MTC, whose family member has had MTC, or who has Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Report a neck lump or swelling, difficulty swallowing, shortness of breath or lasting hoarseness to your provider.2,9

Do not take semaglutide if

  • You have had MTC, a close relative has had it, or you have MEN 2.
  • You have ever reacted to semaglutide, or to another ingredient in the product, with a serious allergy.

Tell your provider before you start if you

  • Have had pancreatitis, gallbladder disease or kidney problems.
  • Have type 2 diabetes, diabetic eye disease (retinopathy), or use insulin or a sulfonylurea.
  • Have severe slowing of the stomach (gastroparesis).
  • Have surgery or a procedure planned with anesthesia or deep sedation.
  • Are pregnant, planning a pregnancy or breastfeeding. Semaglutide should be stopped at least 2 months ahead of a planned pregnancy, and breastfeeding is not recommended with the tablets.
  • Already take a GLP-1 medicine, including any other form of semaglutide.

Sources

  1. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384:989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
  2. Wegovy (semaglutide) injection and tablets prescribing information. Novo Nordisk. Revised June 2026. https://www.novo-pi.com/wegovy.pdf
  3. U.S. Food and Drug Administration. FDA’s concerns with unapproved GLP-1 drugs used for weight loss. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
  4. Aronne LJ, et al. Tirzepatide as compared with semaglutide for the treatment of obesity (SURMOUNT-5). N Engl J Med. 2025;393:26-36. https://pubmed.ncbi.nlm.nih.gov/40353578/
  5. Novo Nordisk. Wegovy savings offer terms and conditions. https://www.wegovyterms.com
  6. Novo Nordisk. Ozempic savings offer terms and conditions. https://www.savingscardeligibility.com
  7. Garvey WT, et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat Med. 2022;28:2083-2091. https://pubmed.ncbi.nlm.nih.gov/36216945/
  8. Rubino D, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity (STEP 4). JAMA. 2021;325:1414-1425. https://pubmed.ncbi.nlm.nih.gov/33755728/
  9. Ozempic (semaglutide) injection prescribing information. Novo Nordisk. Revised May 2026. https://www.novo-pi.com/ozempic.pdf
  10. Rybelsus and Ozempic (semaglutide) tablets prescribing information. Novo Nordisk. Revised January 2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/213051Orig1s030lbl.pdf
  11. U.S. Food and Drug Administration. Approval package, Ozempic (semaglutide) injection, NDA 209637. December 5, 2017. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/209637Orig1s000Approv.pdf
  12. U.S. Food and Drug Administration. FDA requires safety labeling changes for GLP-1 receptor agonists due to potential increased risk of rare but serious eye condition. November 9, 2026. https://www.fda.gov/drugs/drug-safety-communications/fda-requires-safety-labeling-changes-glucagon-peptide-1-receptor-agonists-glp-1-ras-due-potential
  13. Frías JP, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2). N Engl J Med. 2021;385:503-515. https://pubmed.ncbi.nlm.nih.gov/34170647/
  14. Zepbound (tirzepatide) prescribing information. Eli Lilly and Company. Revised August 2026. https://pi.lilly.com/us/zepbound-uspi.pdf
  15. Mounjaro (tirzepatide) prescribing information. Eli Lilly and Company. Revised August 2026. https://pi.lilly.com/us/mounjaro-uspi.pdf
  16. Novo Nordisk. NovoCare Pharmacy home delivery. https://www.novocare.com/pharmacy.html
  17. Novo Nordisk. Wegovy list price. https://www.novopricing.com/wegovy.html
  18. Novo Nordisk. Ozempic list price. https://www.novopricing.com/ozempic.html
  19. Medicare.gov. Weight loss drugs (Medicare GLP-1 Bridge). https://www.medicare.gov/glp1bridge
  20. KFF. 2026 Employer Health Benefits Survey. October 2026. https://www.kff.org/health-costs/2026-employer-health-benefits-survey/
  21. U.S. Food and Drug Administration. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. Updated April 1, 2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize
  22. U.S. Food and Drug Administration. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-providers-compounders-and-patients-dosing-errors-associated-compounded

All sources accessed November 18, 2026. Reviewed by the Zealthy care team.

Find out whether semaglutide is right for you

Answer a few health questions online and a licensed provider will go through your options with you. The first month of membership is $39.

Get Started